Literature DB >> 27247372

Optimal Minimal Panels of Immunohistochemistry for Diagnosis of B-Cell Lymphoma for Application in Countries With Limited Resources and for Triaging Cases Before Referral to Specialist Centers.

Maria Giulia Disanto1, Maria Raffaella Ambrosio2, Bruno Jim Rocca2, Hazem A H Ibrahim3, Lorenzo Leoncini2, Kikkeri N Naresh4.   

Abstract

OBJECTIVES: Establish and validate optimal minimal immunohistochemistry panels for usage in a staged algorithmic manner for precise diagnosis of B-cell lymphomas in countries with limited resources. Suggest short panels of immunostains to be used in referring units that refer suspected lymphomas to specialist diagnostic centers in resourceful countries.
METHODS: Significant proportion of six B-cell lymphomas has characteristic morphology requiring a short panel of confirmatory immunostains. The rest would go through five different algorithms.
RESULTS: 812 cases in which a B-cell lymphoma or an HIV-associated lymphoma was suspected on morphological grounds were evaluated. This led to arriving at a specific diagnosis of 799 B-cell lymphomas. A correct diagnosis was achievable in 69% cases with the application of three to five antibodies; others required additional work-up.
CONCLUSIONS: The panels/algorithms assist pathologists in practicing lymphoma diagnostics in countries with limited resources and in making lymphoma referrals to specialist centers. © American Society for Clinical Pathology, 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  B-cell lymphoma; Classification; Developing countries; Diagnosis; Immunohistochemistry; Lymphoma

Mesh:

Substances:

Year:  2016        PMID: 27247372     DOI: 10.1093/ajcp/aqw060

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Standardization of Manual Method of Immunohistochemical Staining for Breast Cancer Biomarkers at Tertiary Cancer Care Center: An Audit.

Authors:  Manjit K Rana; Amrit Pal S Rana; Aklank Jain; Akhilesh Pathak; Utkarshni Khera; Uttam Sharma; Akriti Jindal; Karuna Singh
Journal:  Cureus       Date:  2022-06-08

Review 2.  Molecular Diagnostic Review of Diffuse Large B-Cell Lymphoma and Its Tumor Microenvironment.

Authors:  Robert Ta; David Yang; Christian Hirt; Thomas Drago; Richard Flavin
Journal:  Diagnostics (Basel)       Date:  2022-04-27

3.  Distinct pattern of lymphoid neoplasms characterizations according to the WHO classification (2016) and prevalence of associated Epstein-Barr virus infection in Nigeria population.

Authors:  Ijeoma C Uzoma; Idowu A Taiwo; Massimo Granai; Gioia Di Stefano; Ester Sorrentino; Sussana Mannucci; Muheez A Durosinmi; Stefano Lazzi; Lorenzo Leoncini; Oluyemi Akinloye
Journal:  Infect Agent Cancer       Date:  2021-05-24       Impact factor: 2.965

Review 4.  Point Mutation Specific Antibodies in B-Cell and T-Cell Lymphomas and Leukemias: Targeting IDH2, KRAS, BRAF and Other Biomarkers RHOA, IRF8, MYD88, ID3, NRAS, SF3B1 and EZH2.

Authors:  Kunwar Singh; Sumanth Gollapudi; Sasha Mittal; Corinn Small; Jyoti Kumar; Robert S Ohgami
Journal:  Diagnostics (Basel)       Date:  2021-03-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.